Literature DB >> 23558141

Enterobacter cloacae producing an uncommon class A carbapenemase, IMI-1, from Singapore.

Jeanette W P Teo1, My-Van La2, Prabha Krishnan3, Brenda Ang4, Roland Jureen1, Raymond T P Lin1.   

Abstract

In this study, we describe the characterization of an infrequently encountered class A carbapenemase, IMI-1, from a clinical Enterobacter cloacae isolate. The isolate had high levels of resistance to carbapenems but retained susceptibility to expanded-spectrum cephalosporins. The blaIMI-1 gene was chromosomally encoded. Detection of the IMI-1 producer highlights the diversity of carbapenemases in a local clinical setting.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23558141     DOI: 10.1099/jmm.0.053363-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  12 in total

1.  In Vitro Activities of Ceftazidime-Avibactam, Aztreonam-Avibactam, and a Panel of Older and Contemporary Antimicrobial Agents against Carbapenemase-Producing Gram-Negative Bacilli.

Authors:  Shawn Vasoo; Scott A Cunningham; Nicolynn C Cole; Peggy C Kohner; Sanjay R Menon; Kevin M Krause; Kelly A Harris; Partha P De; Tse Hsien Koh; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

2.  Characterization of a Novel Putative Xer-Dependent Integrative Mobile Element Carrying the bla(NMC-A) Carbapenemase Gene, Inserted into the Chromosome of Members of the Enterobacter cloacae Complex.

Authors:  Alberto Antonelli; Marco Maria D'Andrea; Vincenzo Di Pilato; Bruno Viaggi; Francesca Torricelli; Gian Maria Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2015-07-27       Impact factor: 5.191

3.  In Vitro Activity of Imipenem-Relebactam and Ceftolozane-Tazobactam against Resistant Gram-Negative Bacilli.

Authors:  Suzannah M Schmidt-Malan; Avisya J Mishra; Ammara Mushtaq; Cassandra L Brinkman; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2018-07-27       Impact factor: 5.191

4.  Carbapenem- and Colistin-Resistant Enterobacter cloacae from Delta, Colorado, in 2015.

Authors:  Andrew P Norgan; Jarred M Freese; Patricia M Tuin; Scott A Cunningham; Patricio R Jeraldo; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

5.  In Vitro Activity of Plazomicin Compared to Amikacin, Gentamicin, and Tobramycin against Multidrug-Resistant Aerobic Gram-Negative Bacilli.

Authors:  Wim A Fleischmann; Kerryl E Greenwood-Quaintance; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2020-01-27       Impact factor: 5.191

Review 6.  Structural and Functional Aspects of Class A Carbapenemases.

Authors:  Thierry Naas; Laurent Dortet; Bogdan I Iorga
Journal:  Curr Drug Targets       Date:  2016       Impact factor: 3.465

7.  Dissemination of carbapenemase-producing Enterobacteriaceae harbouring blaNDM or blaIMI in local market foods of Yangon, Myanmar.

Authors:  Yo Sugawara; Hideharu Hagiya; Yukihiro Akeda; Mya Mya Aye; Hpoo Pwint Myo Win; Noriko Sakamoto; Rathina Kumar Shanmugakani; Dan Takeuchi; Isao Nishi; Akiko Ueda; Moh Moh Htun; Kazunori Tomono; Shigeyuki Hamada
Journal:  Sci Rep       Date:  2019-10-08       Impact factor: 4.379

8.  Detection of blaIMP4 and blaNDM1 harboring Klebsiella pneumoniae isolates in a university hospital in Malaysia.

Authors:  Nurul Izzati Hamzan; Chan Yean Yean; Rosliza Abdul Rahman; Habsah Hasan; Zaidah Abdul Rahman
Journal:  Emerg Health Threats J       Date:  2015-03-10

9.  Complete Nucleotide Sequence of pGA45, a 140,698-bp IncFIIY Plasmid Encoding bla IMI-3-Mediated Carbapenem Resistance, from River Sediment.

Authors:  Bingjun Dang; Daqing Mao; Yi Luo
Journal:  Front Microbiol       Date:  2016-02-24       Impact factor: 5.640

Review 10.  Carbapenem Resistance in Gram-Negative Bacteria: The Not-So-Little Problem in the Little Red Dot.

Authors:  Jocelyn Qi Min Teo; Yiying Cai; Tze-Peng Lim; Thuan Tong Tan; Andrea Lay-Hoon Kwa
Journal:  Microorganisms       Date:  2016-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.